Newsfeeds - Spark Newswire

1 minute read

Xeris Pharmaceuticals Enters Collaboration Agreement With Merck; Financial Terms Not Disclosed

Today, 6:33 AM

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology, today announced a

MRK

6 minute read

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

By Shanthi Rexaline

Today, 6:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11)

ABSI

8 minute read

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

By Shanthi Rexaline

Today, 6:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)

ABIO

4 minute read

45 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:33 AM

Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.

AEHR

3 minute read

28 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 6:33 AM

Gainers Camber Energy, Inc.. (NYSE: CEI) jumped 44.2% to $1.3102 after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.

AEHR

1 minute read

Events
News

Xeris Pharmaceuticals To Present At Oppenheimer Fall Healthcare Life Sciences & MedTech Summit On Wednesday, Sept. 22

By Benzinga Newsdesk

Today, 6:33 AM

Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced that Paul R. Edick,

XERS